Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
NCT: NCT07632742 · RECRUITING
NCT IDNCT07632742
StatusRECRUITING
Start Date2026-06
Completion2028-06
SponsorNorthwestern University (OTHER)
First posted
Last updated
Brief Summary
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Frequently Asked Questions
What is Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial?
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial is a clinical trial registered under NCT07632742. Current status: RECRUITING.
What is the status of NCT07632742?
The current status of NCT07632742 (Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial) is: RECRUITING.
When did Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial start?
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial started on 2026-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.